VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Crystal Pharmatech Supports Langlai Technology’s Class 1 Innovative Drug Lanrucopan Hydrochloride Tablets Approval
Crystal Pharmatech Supports Langlai Technology’s Class 1 Innovative Drug Lanrucopan Hydrochloride Tablets Approval
Jun 15, 2026 08:00 CST Updated 10:52
Share:
